Scarica l'app Stockscreener
14.44
2.30%
-0.34
Dopo l'orario di chiusura:
14.61
0.17
+1.18%
Precedente Chiudi:
$14.78
Aprire:
$14.76
Volume 24 ore:
22,782
Relative Volume:
0.17
Capitalizzazione di mercato:
$65.31M
Reddito:
-
Utile/perdita netta:
$-24.77M
Rapporto P/E:
-19.78
EPS:
-0.73
Flusso di cassa netto:
$-17.36M
1 W Prestazione:
-0.76%
1M Prestazione:
-1.03%
6M Prestazione:
+84.42%
1 anno Prestazione:
+109.28%
Intervallo 1D:
$14.40
$15.00
Intervallo di 1 settimana:
$13.81
$15.00
Portata 52W:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Nome
Mink Therapeutics Inc
Settore
Industria
Telefono
212-994-8250
Indirizzo
149 FIFTH AVENUE, NEW YORK
Confronta INKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
14.44 | 64.00M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | Downgrade | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Borsa (INKT) Ultime notizie
Price momentum metrics for MiNK Therapeutics Inc. explainedEarnings Performance Report & Risk Managed Trade Strategies - newser.com
Applying big data sentiment scoring on MiNK Therapeutics Inc.Dollar Strength & AI Enhanced Trading Alerts - newser.com
Why MiNK Therapeutics Inc. stock could see breakout soon2025 Dividend Review & Smart Allocation Stock Tips - newser.com
MiNK Therapeutics Inc. stock trend forecast2025 Retail Activity & Verified Entry Point Signals - newser.com
Is MiNK Therapeutics Inc. stock safe for conservative investorsJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
Why MiNK Therapeutics Inc. is moving todayQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationProfit Target & Verified Stock Trade Ideas - newser.com
How to monitor MiNK Therapeutics Inc. with trend dashboardsInflation Watch & Real-Time Chart Pattern Alerts - newser.com
Published on: 2025-10-13 07:00:17 - newser.com
Why MiNK Therapeutics Inc. stock is popular among millennials2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Chart based analysis of MiNK Therapeutics Inc. trendsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
MiNK Therapeutics Inc.’s volatility index tracking explainedWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
Best data tools to analyze MiNK Therapeutics Inc. stockJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Reversal indicators forming on MiNK Therapeutics Inc. stockJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for MiNK Therapeutics (NASDAQ:INKT) - MarketBeat
MiNK Therapeutics (NASDAQ:INKT) Stock Price Down 2.1% – Here’s Why - Defense World
How to escape a deep drawdown in MiNK Therapeutics Inc.Fed Meeting & Real-Time Sentiment Analysis - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Tools to assess MiNK Therapeutics Inc.’s risk profileJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
MiNK Therapeutics Inc. stock prediction for this weekQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Evaluating MiNK Therapeutics Inc. with trendline analysisQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves in volatile trading sessions2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - newser.com
Risk vs reward if holding onto MiNK Therapeutics Inc.2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
What analysts say about MiNK Therapeutics Inc stockFundamental Stock Analysis & Fast Profit Portfolio Plans - earlytimes.in
Published on: 2025-10-03 05:09:10 - earlytimes.in
LakeShore Biopharma (NASDAQ:LSB) & MiNK Therapeutics (NASDAQ:INKT) Financial Survey - Defense World
MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board By Investing.com - Investing.com Nigeria
What analysts say about MiNK Therapeutics Inc 6Q40 stockQuarterly Earnings Review & Free Discover Massive Upside Stocks - earlytimes.in
MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board - Investing.com
Mink Therapeutics Inc Azioni (INKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):